Symptom Clusters of Patients with Advanced Thyroid Cancer: a Cross-sectional Study

Overview

Journal Endocrine

Specialty Endocrinology

Date 2024 Sep 25

PMID 39320592

Authors

Ming Cai

Juxiang Gou

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate and analyze the symptom clusters of patients with advanced thyroid cancer and provide a basis for developing targeted symptom management measures.

Methods: Patients who visited a multidisciplinary outpatient service for advanced thyroid cancer at a tertiary A hospital in Sichuan Province from April 2022 to April 2023 were selected using convenience sampling. A cross-sectional survey was conducted using the M.D. Anderson Symptom Inventory-Thyroid Cancer module (MDASI-THY). Symptom clusters were extracted by exploratory factor analysis.

Results: Disturbed sleep had the highest incidence (75.7%) and severity (3.0 points), while mood distress had the highest incidence (63.5%) and severity (2.0 points) of symptom interference. Three symptom clusters were identified: mood-fatigue-sleep, digestive tract-sensation, and thyroid cancer-specific symptom clusters.

Conclusion: Patients with advanced thyroid cancer have multiple symptom clusters that seriously affect their daily lives. Health care professionals should conduct targeted observation and preventive treatment to reduce the burden of symptoms on patients.

References

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Hay I, McConahey W, Goellner J . Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002; 113:241-60. PMC: 2194488. View

Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M . Update on Fundamental Mechanisms of Thyroid Cancer. Front Endocrinol (Lausanne). 2020; 11:102. PMC: 7082927. DOI: 10.3389/fendo.2020.00102. View

Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli J . Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006; 91(8):2892-9. DOI: 10.1210/jc.2005-2838. View

Townes T, Navuluri S, Pytynia K, Gunn G, Kamal M, Gilmore K . Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic. Head Neck. 2020; 42(8):1919-1927. DOI: 10.1002/hed.26119. View

Li Y, Li X, Mao C, Lv G, Xie Z, Jiang H . Symptom clusters in head and neck cancer patients with endotracheal tube: Which symptom clusters are independently associated with health-related quality of life?. Eur J Oncol Nurs. 2020; 48:101819. DOI: 10.1016/j.ejon.2020.101819. View

Kim H, McGuire D, Tulman L, Barsevick A . Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005; 28(4):270-82. DOI: 10.1097/00002820-200507000-00005. View

Aktas A . Cancer symptom clusters: current concepts and controversies. Curr Opin Support Palliat Care. 2013; 7(1):38-44. DOI: 10.1097/SPC.0b013e32835def5b. View

Kwekkeboom K . Cancer Symptom Cluster Management. Semin Oncol Nurs. 2016; 32(4):373-382. PMC: 5143160. DOI: 10.1016/j.soncn.2016.08.004. View

10.

Cabanillas M, Williams M, Gunn G, Weitzman S, Burke L, Busaidy N . Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck. 2017; 39(7):1291-1295. DOI: 10.1002/hed.24784. View

11.

Gning I, Trask P, Mendoza T, Harle M, Gutierrez K, Kitaka S . Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology. 2008; 76(1):59-68. DOI: 10.1159/000178809. View

12.

Alhashemi A, Jones J, Goldstein D, Ezzat S, Sawka A . Re: Quality of life and symptom impact of thyroid cancer: A cross-sectional survey of Canadian patients. Surgery. 2018; 166(5):948-949. DOI: 10.1016/j.surg.2018.09.018. View

13.

Hu Z, Gou J, Cai M, Zhang Y . Translation and validation of M.D. Anderson Symptom Inventory-Thyroid Cancer module in Chinese thyroid cancer patients: a cross-sectional and methodological study. BMC Cancer. 2022; 22(1):924. PMC: 9419372. DOI: 10.1186/s12885-022-09995-2. View

14.

Strebkova R . Cancer-related Fatigue in Patients with Oncological Diseases: Causes, Prevalence, Guidelines for Assessment and Management. Folia Med (Plovdiv). 2021; 62(4):679-689. DOI: 10.3897/folmed.62.e50517. View

15.

Thong M, van Noorden C, Steindorf K, Arndt V . Cancer-Related Fatigue: Causes and Current Treatment Options. Curr Treat Options Oncol. 2020; 21(2):17. PMC: 8660748. DOI: 10.1007/s11864-020-0707-5. View

16.

Hanna E, Mendoza T, Rosenthal D, Gunn G, Sehra P, Yucel E . The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2014; 121(5):766-73. PMC: 4339345. DOI: 10.1002/cncr.29097. View

17.

Kirkova J, Aktas A, Walsh D, Davis M . Cancer symptom clusters: clinical and research methodology. J Palliat Med. 2011; 14(10):1149-66. DOI: 10.1089/jpm.2010.0507. View

18.

Filetti S, Durante C, Hartl D, Leboulleux S, Locati L, Newbold K . Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019; 30(12):1856-1883. DOI: 10.1093/annonc/mdz400. View

19.

Hsiao C, Loescher L, Moore I . Symptoms and symptom distress in localized prostate cancer. Cancer Nurs. 2007; 30(6):E19-32. DOI: 10.1097/01.NCC.0000300163.13639.bc. View

20.

Cuthbert C, Boyne D, Yuan X, Hemmelgarn B, Cheung W . Patient-reported symptom burden and supportive care needs at cancer diagnosis: a retrospective cohort study. Support Care Cancer. 2020; 28(12):5889-5899. DOI: 10.1007/s00520-020-05415-y. View